Division of Vascular and Endovascular Surgery, University of Texas Health Science, Houston, Tex.
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, Minn.
J Vasc Surg. 2021 Mar;73(3):805-818.e2. doi: 10.1016/j.jvs.2020.06.123. Epub 2020 Jul 21.
The objective of this study was to evaluate the impact of intentional coverage of accessory renal arteries (ARAs) on renal outcomes after fenestrated-branched endovascular aortic repair (FB-EVAR) for pararenal aortic aneurysms or thoracoabdominal aortic aneurysms.
We analyzed the clinical data of 296 patients enrolled in a prospective nonrandomized study to evaluate outcomes of FB-EVAR between 2013 and 2018. Patients with solitary kidneys, intraoperative loss of main renal arteries, or pre-existing stage V chronic kidney disease were excluded. Two groups were analyzed: patients with intentional ARA coverage; and controls, who had complete preservation. End points included 30-day mortality; major adverse events; acute kidney injury (AKI), defined by RIFLE criteria (Risk, Injury, Failure, Loss of kidney function, and End-stage renal disease); renal function deterioration (RFD), defined by >30% decline in baseline estimated glomerular filtration rate; and presence of renal infarcts.
There were 254 patients (184 male; mean age, 75 ± 8 years) included in the study, 56 (22%) with intentional ARA coverage and 198 controls, of whom 16 had ARA preservation. ARA diameter was smaller in patients who had intentional coverage vs preservation (2.7 ± 0.9 mm vs 3.4 ± 0.2 mm; P < .001). There was no difference in demographics, cardiovascular risk factors, and aneurysm extent. All ARAs intended to be incorporated were successfully stented. Patients with ARA coverage had a higher frequency of kidney infarction (75% vs 25%; P < .001). There were two (1%) deaths within 30 days, both among controls. Patients with ARA coverage had more major adverse events (32% vs 19%; P = .04) because of higher incidence of AKI (21% vs 9%; P = .02). None of the 16 patients who had ARA preservation developed AKI. At 3 years, freedom from RFD was lower for patients who had ARA coverage compared with controls (55% ± 9% vs 76% ± 5%; log-rank, P = .02). By multivariate analysis, predictors of AKI were ARA coverage (odds ratio, 2.8; 95% confidence interval [CI], 1.2-6.2; P = .01) and estimated blood loss >1 L (odds ratio, 3.8; 95% CI, 1.2-12.3; P = .03). Postoperative AKI (hazard ratio [HR], 4.4; 95% CI, 2.4-8.1; P < .001), renal reintervention for stenosis (HR, 3.2; 95% CI, 1.6-6.7; P = .002), aneurysm diameter (HR, 1.04; 95% CI, 1.02-1.06; P < .001), and ARA coverage (HR, 2.0; 95% CI, 2.4-8.1; P = .02) were predictors of RFD.
Intentional ARA coverage during FB-EVAR was associated with a threefold increase in AKI and with lower freedom from RFD. Factors associated with RFD included postoperative AKI, renal reinterventions for stenosis, and ARA coverage. Incorporation of ARAs during FB-EVAR, when it is technically feasible, helps decrease risk of AKI and RFD.
本研究旨在评估在 2013 年至 2018 年间对肾周腹主动脉瘤或胸腹主动脉瘤行开窗分支腔内血管修复术(fenestrated-branched endovascular aortic repair,FB-EVAR)时,故意覆盖副肾动脉(accessory renal arteries,ARAs)对肾功能结果的影响。
我们分析了 2013 年至 2018 年期间行 FB-EVAR 的 296 例前瞻性非随机研究的临床数据。排除了孤立肾、术中主肾动脉丢失或已有终末期肾病的患者。分析了两组患者:一组是故意覆盖 ARAs 的患者;另一组是完全保留 ARAs 的对照组。终点包括 30 天死亡率;主要不良事件;急性肾损伤(acute kidney injury,AKI),定义为 RIFLE 标准(风险、损伤、衰竭、丧失肾功能和终末期肾病);肾功能恶化(renal function deterioration,RFD),定义为基础估计肾小球滤过率下降>30%;以及存在肾梗死。
研究共纳入 254 例患者(184 例男性;平均年龄 75±8 岁),其中 56 例(22%)故意覆盖 ARAs,198 例对照组,其中 16 例保留了 ARAs。与保留 ARAs 的患者相比,故意覆盖 ARAs 的患者 ARAs 直径较小(2.7±0.9mm 比 3.4±0.2mm;P<0.001)。两组患者的人口统计学、心血管危险因素和动脉瘤范围均无差异。所有计划纳入的 ARAs 均成功进行了支架置入。覆盖 ARAs 的患者肾梗死发生率更高(75%比 25%;P<0.001)。对照组有 2 例(1%)患者在 30 天内死亡。覆盖 ARAs 的患者主要不良事件发生率更高(32%比 19%;P=0.04),因为 AKI 发生率更高(21%比 9%;P=0.02)。16 例保留 ARAs 的患者均未发生 AKI。3 年时,与对照组相比,覆盖 ARAs 的患者发生 RFD 的几率更低(55%±9%比 76%±5%;对数秩检验,P=0.02)。多变量分析显示,AKI 的预测因素是 ARAs 覆盖(比值比,2.8;95%置信区间,1.2-6.2;P=0.01)和估计失血量>1L(比值比,3.8;95%置信区间,1.2-12.3;P=0.03)。术后 AKI(风险比[HR],4.4;95%置信区间,2.4-8.1;P<0.001)、因狭窄行肾再介入治疗(HR,3.2;95%置信区间,1.6-6.7;P=0.002)、动脉瘤直径(HR,1.04;95%置信区间,1.02-1.06;P<0.001)和 ARAs 覆盖(HR,2.0;95%置信区间,2.4-8.1;P=0.02)是 RFD 的预测因素。
在 FB-EVAR 术中故意覆盖 ARAs 与 AKI 发生率增加三倍以及 RFD 降低有关。与 RFD 相关的因素包括术后 AKI、因狭窄行肾再介入治疗和 ARAs 覆盖。在技术可行的情况下,在 FB-EVAR 中纳入 ARAs 有助于降低 AKI 和 RFD 的风险。